382 results on '"Klok, Frederikus A"'
Search Results
2. Aspin: neurosurgical aspirin intervention prognostic study — perioperative continuation versus discontinuation of aspirin in lumbar spinal surgery, a randomized controlled, noninferiority trial
3. The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer
4. Incidence and clinical course of chronic thromboembolic pulmonary hypertension with or without a history of venous thromboembolism in Denmark
5. Effectiveness of rehabilitation programmes targeting quality of life, psychological wellbeing, and functional capacity in pulmonary embolism survivors; a systematic review and best evidence synthesis
6. Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma
7. The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization
8. Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study
9. Computed tomography diagnosis of pulmonary infarction in acute pulmonary embolism
10. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021
11. Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
12. Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial
13. Functional limitations 3 and 12 months after venous thromboembolism: a cohort study
14. Splanchnic vein thrombosis in necrotizing pancreatitis: a post-hoc analysis of a nationwide prospective cohort
15. Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: A scoping review
16. High-risk pulmonary embolism in the intensive care unit
17. Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020
18. American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary
19. Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism
20. Risk assessment and management strategies in older patients with acute pulmonary embolism
21. Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study
22. Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review
23. RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study
24. Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study
25. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
26. Accuracy of physicians’ intuitive risk estimation in the diagnostic management of pulmonary embolism: an individual patient data meta-analysis
27. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
28. Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation
29. The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
30. Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
31. Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy
32. Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism
33. Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older
34. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review
35. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism
36. Outcomes of venous thromboembolism care: future directions
37. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
38. Atrial fibrillation, cancer and anticancer drugs
39. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study
40. Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism
41. Cross-cultural validity of the Pulmonary Embolism Quality of Life questionnaire in the quality of life survey after pulmonary embolism: A Persian-speaking cohort
42. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data
43. Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice
44. Treatment and prevention of cancer-associated thrombosis in the Netherlands: A national survey
45. Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study
46. Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma
47. The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study
48. Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry
49. Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
50. Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.